Graft Failure Incidence, Risk Factors, and Outcomes in Patients Undergoing Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide

Mata, J. R., Zahurak, M., Rosen, N., DeZern, A. E., Jones, R. J., & Ambinder, A. J. (2024). Graft Failure Incidence, Risk Factors, and Outcomes in Patients Undergoing Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide. Transplantation and Cellular Therapy, 30(6), 588–596. https://doi.org/10.1016/j.jtct.2024.03.018
Authors:
Jonaphine Rae Mata
Marianna Zahurak
Natalie Rosen
Amy E DeZern
Richard J Jones
Alexander J Ambinder
Affiliated Authors:
Natalie Rosen
Columbia Affiliation:
Subjects:
Hematopoietic Stem Cell Transplantation (MeSH)
Cyclophosphamide (MeSH)
Graft vs Host Disease (MeSH)
Transplantation, Homologous (MeSH)
Author Keywords:
allogeneic hematopoietic cell transplant
graft failure
non-myeloablative conditioning
post-transplant cyclophosphamide
allogeneic hematopoietic cell
post-transplant
cyclophosphamide
non-myeloablative
conditioning
elink
Publication Type:
Article
Unique ID:
10.1016/j.jtct.2024.03.018
PMID:
38521411
DOI:
10.1016/j.jtct.2024.03.018
Journal:
Transplantation and Cellular Therapy
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: